Adding a New Piece to the ASGR1 Puzzle: ANGPTL3.
作者信息
Garcia-Arcos Itsaso
机构信息
SUNY Downstate Health Sciences University, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Department of Cell Biology, Brooklyn, NY.
出版信息
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2450-2452. doi: 10.1161/ATVBAHA.124.321882. Epub 2024 Oct 31.
Abstract
摘要
相似文献
1
Adding a New Piece to the ASGR1 Puzzle: ANGPTL3.为ASGR1谜题增添新拼图块：血管生成素样蛋白3（ANGPTL3）
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2450-2452. doi: 10.1161/ATVBAHA.124.321882. Epub 2024 Oct 31.
2
ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux.ASGR1 缺乏通过调节脂蛋白代谢和促进胆固醇外排抑制西方饮食喂养小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2428-2449. doi: 10.1161/ATVBAHA.124.321076. Epub 2024 Oct 10.
3
ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity.ANGPTL3（血管生成素样蛋白 3）在人体循环中优先存在于高密度脂蛋白上，影响其活性。
J Am Heart Assoc. 2023 Nov 7;12(21):e030476. doi: 10.1161/JAHA.123.030476. Epub 2023 Oct 27.
4
Angiopoietin-like 3 in lipoprotein metabolism.载脂蛋白样蛋白 3 在脂蛋白代谢中的作用。
Nat Rev Endocrinol. 2017 Dec;13(12):731-739. doi: 10.1038/nrendo.2017.119. Epub 2017 Oct 6.
5
Circulating ANGPTL3/8 Concentrations Are Associated With an Atherogenic Lipoprotein Profile and Increased CHD Risk in Swedish Population-Based Studies.在瑞典基于人群的研究中，循环血管生成素样蛋白3/8（ANGPTL3/8）浓度与致动脉粥样硬化脂蛋白谱及冠心病风险增加相关。
Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):443-451. doi: 10.1161/ATVBAHA.124.321308. Epub 2025 Jan 30.
6
Correlation between betatrophin/angiogenin-likeprotein3/lipoprotein lipase pathway and severity of coronary artery disease in Kazakh patients with coronary heart disease.哈萨克族冠心病患者中β-促细胞生成素/血管生成素样蛋白3/脂蛋白脂肪酶通路与冠状动脉疾病严重程度的相关性
World J Clin Cases. 2022 Mar 6;10(7):2095-2105. doi: 10.12998/wjcc.v10.i7.2095.
7
Genetic Risk Scores in Premature Coronary Artery Disease: Still Only One Piece of the Prevention Puzzle.早发性冠状动脉疾病中的遗传风险评分：仍然只是预防难题中的一部分。
Circ Genom Precis Med. 2018 Jan;11(1):e002006. doi: 10.1161/CIRCGEN.117.002006.
8
Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity.循环 ANGPTL3 和 ANGPTL4 水平可预测冠状动脉粥样硬化严重程度。
Lipids Health Dis. 2021 Nov 6;20(1):154. doi: 10.1186/s12944-021-01580-z.
9
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis.ANGPTL3 作为高血脂和动脉粥样硬化的药物靶点。
Curr Atheroscler Rep. 2022 Dec;24(12):959-967. doi: 10.1007/s11883-022-01071-1. Epub 2022 Nov 11.
10
Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.血管生成素样蛋白 3 缺乏与胰岛素敏感性增加、脂蛋白脂肪酶活性增加和血清游离脂肪酸减少有关。
Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1706-13. doi: 10.1161/ATVBAHA.113.301397. Epub 2013 May 9.
本文引用的文献
1
ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux.ASGR1 缺乏通过调节脂蛋白代谢和促进胆固醇外排抑制西方饮食喂养小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2428-2449. doi: 10.1161/ATVBAHA.124.321076. Epub 2024 Oct 10.
2
Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress.ASGR1 缺乏通过增加 GP73 介导的肝内质网应激促进肝损伤。
Nat Commun. 2024 Mar 8;15(1):1908. doi: 10.1038/s41467-024-46135-9.
3
ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity.ASGR1 缺乏会使脂肪组织内的脂质分流，但在肥胖期间会导致肝脏损伤。
Cardiovasc Diabetol. 2024 Jan 28;23(1):42. doi: 10.1186/s12933-023-02099-6.
4
Impact of Asialoglycoprotein Receptor and Mannose Receptor Deficiency on Murine Plasma N-glycome Profiles.去唾液酸糖蛋白受体和甘露糖受体缺陷对小鼠血浆 N-糖组谱的影响。
Mol Cell Proteomics. 2023 Sep;22(9):100615. doi: 10.1016/j.mcpro.2023.100615. Epub 2023 Jul 4.
5
Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion.抑制 ASGR1 通过促进胆固醇排泄来降低血脂水平。
Nature. 2022 Aug;608(7922):413-420. doi: 10.1038/s41586-022-05006-3. Epub 2022 Aug 3.
6
Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression.功能获得性 ASGR1 通过 INSIG1 介导的 SREBP 信号抑制来调节脂质稳态。
JCI Insight. 2021 Oct 8;6(19):e147038. doi: 10.1172/jci.insight.147038.
7
ANGPTL3 as therapeutic target.ANGPTL3 作为治疗靶点。
Curr Opin Lipidol. 2021 Dec 1;32(6):335-341. doi: 10.1097/MOL.0000000000000789.
8
Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin.Asialoglycoprotein 受体 1 是一种新型的 PCSK9 非依赖性配体，可被弗林蛋白酶切割肝脏 LDLR。
J Biol Chem. 2021 Oct;297(4):101177. doi: 10.1016/j.jbc.2021.101177. Epub 2021 Sep 8.
9
Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages.神经氨酸酶 1 和 3 通过脱唾液酸化低密度脂蛋白并增加其被巨噬细胞摄取来引发动脉粥样硬化。
J Am Heart Assoc. 2021 Feb 16;10(4):e018756. doi: 10.1161/JAHA.120.018756. Epub 2021 Feb 6.
10
Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis.蛋白糖基化对脂蛋白代谢和动脉粥样硬化的影响。
Cardiovasc Res. 2021 Mar 21;117(4):1033-1045. doi: 10.1093/cvr/cvaa252.
Zotero 插件